NCT03816280

Brief Summary

Type 2 diabetes mellitus (T2DM) poses a significant burden on the patients and the health care system. The increasing number of surgery performed in elderly population results in an increased number of perioperative T2DM-related adverse effects. T2DM has a prevalence of 30-40% in a population undergoing cardiovascular surgery. Cardiac surgery, especially cardiopulmonary bypass (CPB) is also known to deteriorate cerebral oxygenation. Furthermore, acid-base balance of patients undergoing CPB can be managed using two main regimes: alpha-stat and pH-stat. The use of pH-stat acid-base management involves maintaining the patient's temperature-corrected pH at a constant level (7.40) and maintaining normocapnia (pCO2 of 40 mmHg). Alpha-stat acid-base management on the other hand is performed by maintaining the ionization state of histidine by keeping the pH stable when a standardized temperature of 37C is used. Therefore, while a constant pH (7.40) and normocapnia (pCO2 of 40 mmHg) are targeted when measured at 37C, the hypothermia applied during CPB will result in a lower pCO2 and in a relative respiratory alkalosis. Previous studies investigating alpha-stat and pH-stat managements demonstrated increased jugular venous oxygen concentrations when pH-stat management was applied. Therefore, our study is aimed at characterizing the effects of an alpha-stat or pH-stat acid-base management regime on the cerebral oxygenation, parameters of regional cerebral oxygen supply and demand during and following CPB in diabetic patients. These parameters include regional cerebral tissue oxygen saturation (rSO2), central venous oxygen saturation ScvO2) and the physiological saturation gap between ScvO2 and rSO2 (gSO2).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 25, 2019

Completed
7 days until next milestone

Study Start

First participant enrolled

February 1, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
Last Updated

May 16, 2019

Status Verified

May 1, 2019

Enrollment Period

1.4 years

First QC Date

January 22, 2019

Last Update Submit

May 14, 2019

Conditions

Keywords

Spectroscopy, Near-Infrared

Outcome Measures

Primary Outcomes (2)

  • Cerebral tissue oxygen saturation

    The spatially resolved continuous-wave NIRS technique is applied to estimate cerebral tissue oxygen saturation. This monitor uses two different wavelengths (730 and 810 nm) and has two detectors positioned 3 and 4 cm from the light source. Computing the differences between the intensity of the emitted and the reflected light with two receivers allows the measurement of the oxygen saturation of the cerebral cortex. In this study, two adult sensors are applied on the left and right sides of the patient's forehead symmetrically, and the cerebral-tissue oxygen saturation is monitored continuously during the surgical procedures and the data are registered in each protocol stage. The mean value of the rSO2 measured by the sensors is calculated for each protocol stage and used for further analyses.

    Intraoperative interval during cardiac surgery starting from anaesthesia induction until end of the surgery. (approx. 180 minutes, measurements at ~0-40-140-160 minutes).

  • Central venous oxygen saturation

    The central venous oxygen saturation is measured from central venous blood samples (Radiometer ABL 505, Copenhagen, Denmark). The proper positioning of the central venous catheter is verified by the surgeon via manually palpating the catheter tip.

    Intraoperative interval during cardiac surgery starting from anaesthesia induction until end of the surgery. (approx. 180 minutes, measurements at ~0-40-140-160 minutes).

Study Arms (4)

Group T2DM-alpha

Patients with diabetes mellitus undergoing CPB with alpha-stat acid-base management

Procedure: Elective cardiopulmonary bypass (CPB)Procedure: Alpha-stat acid-base management

Group T2DM-pH

Patients with diabetes mellitus undergoing CPB with pH-stat acid-base management

Procedure: Elective cardiopulmonary bypass (CPB)Procedure: pH-stat acid-base management

Group Ctrl-alpha

Control patients undergoing CPB with alpha-stat acid-base management

Procedure: Elective cardiopulmonary bypass (CPB)Procedure: Alpha-stat acid-base management

Group Ctrl-pH

Control patients undergoing CPB with pH-stat acid-base management

Procedure: Elective cardiopulmonary bypass (CPB)Procedure: pH-stat acid-base management

Interventions

All groups undergo elective cardiopulmonary bypass (CPB)

Group Ctrl-alphaGroup Ctrl-pHGroup T2DM-alphaGroup T2DM-pH

Acid-base status during CPB will be maintained using the alpha-stat regime

Group Ctrl-alphaGroup T2DM-alpha

Acid-base status during CPB will be maintained using the pH-stat regime

Group Ctrl-pHGroup T2DM-pH

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The patients enrolled at the Second Department of Internal Medicine and Cardiology Centre Cardiac Surgical Unit, University of Szeged

You may qualify if:

  • Patients undergoing cardiac surgery with or without diabetes mellitus
  • age between 18-80 years

You may not qualify if:

  • patients older than 80 years of age
  • poor ejection fraction (\<40%)
  • unilateral internal carotid stenosis (\>75%)
  • medical history of smoking
  • medical history of chronic obstructive pulmonary disease
  • medical history of stroke

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiology Centre Cardiac Surgical Unit and Second Department of Internal Medicine, University of Szeged

Szeged, Csongrád megye, 6725, Hungary

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Central Study Contacts

Barna Babik, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 22, 2019

First Posted

January 25, 2019

Study Start

February 1, 2019

Primary Completion

July 1, 2020

Study Completion

July 1, 2020

Last Updated

May 16, 2019

Record last verified: 2019-05

Locations